secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0000950170-23-012879
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma director Shalini Sharp resigns; Heidi Hunter named Audit Committee Chair
--------------------------------------------------------------------------------

- Shalini Sharp resigned as Class III director and Audit Committee Chair effective April 10, 2023.
- Resignation not due to any disagreement with management or the Board.
- Heidi Hunter, current Class I director and Audit Committee member, appointed as new Audit Committee Chair effective April 13, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017023012879/0000950170-23-012879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017023012879/stro-20230410.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer